Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
289.20
-2.57 (-0.88%)
Aug 18, 2026, 10:02 AM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13 Dec '12
Revenue from Intangible Royalty Assets
151.16M132.53M95.33M
Income from Financial Royalty Assets
36.95M28.47M13.44M
Royalties Revenue
188.11M161.00M108.77M
Captisol Revenue
35.10M40.21M30.88M
Contract Revenue and Income
67.34M66.87M27.48M
Revenue (Total)
290.54M268.09M167.13M